Lab on Chips Market Scope
A Lab-on-a-chip (LOC) is a miniaturized device that integrates microfluidics and nanotechnology to carry out complex biochemical analyses, such as PCR, microarrays, and protein separation and analysis on a single chip leading to a handheld and portable device. LoC is a devices are capable of scaling the single or multiple laboratory functions down to chip-format. The size of this chip ranges from millimeters to a few square centimeters.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | uFluidix (Canada), Microfluidic ChipShop (Germany), EMD Millipore (United States), 1CellBio, Inc. (United States), Illumina, Inc. (United States), PerkinElmer, Inc. (United States), Agilent Technologies, Inc. (United States) and Dolomite Microfluidics (United Kingdom) |
CAGR | % |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Lab on Chips market throughout the predicted period.
uFluidix (Canada), Microfluidic ChipShop (Germany), EMD Millipore (United States), 1CellBio, Inc. (United States), Illumina, Inc. (United States), PerkinElmer, Inc. (United States), Agilent Technologies, Inc. (United States) and Dolomite Microfluidics (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Rain Dance Technologies, Inc. (United States) and Fluidigm Corporation (United States).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Lab on Chips market by Type , by Application (Drug Discovery, Clinical diagnostics, Biotechnology, Chemistry, Research and Others) and Region with country level break-up.
On the basis of geography, the market of Lab on Chips has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2023.
Market Leaders and their expansionary development strategies
In November 2022, Lam Research Corp. announced that it has completed the acquisition of SEMSYSCO GmbH, a global provider of wet processing semiconductor equipment from Gruenwald Equity and other investors. With the addition of SEMSYSCO, Lam gains capabilities in advanced packaging, ideal for leading-edge logic chips and chiplet-based solutions for high-performance computing (HPC), artificial intelligence (AI) and other data-intensive applications. Financial terms of the agreement were not disclosed.
In September 2023, NETRI, the leading provider of organ-on-chip technologies for pre-clinical neuroscience discovery, have recently announced the launch of a new range of organ-on-chip kits for high-throughput in vitro modeling of the peripheral nervous system.
Influencing Trend:
Improve Portability through Microfluidic Chip
Market Growth Drivers:
Growing Demand for Point-Of-Care Testing and Increasing Applications of Drug Delivery Technologies
Challenges:
Standardization/Commercialization of Microfluidic Devices
Restraints:
Time-Consuming Regulatory Approval Process
Opportunities:
Rising Number of Applications of Microfluidics Technology
Key Target Audience
Manufacturers of Lab on Chip, Suppliers of Lab on Chip, Wholesalers, Distributors and Retailers of Lab on Chip, Healthcare Industry, Academic & Research Institutes and Governmental Bodies